Home  |   About Us  |   Courses  |   Q & A  |   Contact Us     888-844-ACES     www.aces4ce.com

Tuesday, July 22, 2014

Bacteria Responsible for Gum Disease Facilitates Rheumatoid Arthritis

Does gum disease indicate future joint problems? Although researchers and clinicians have long known about an association between two prevalent chronic inflammatory diseases -- periodontal disease and rheumatoid arthritis (RA) -- the microbiological mechanisms have remained unclear.

In an article published today in PLoS Pathogens, University of Louisville School of Dentistry Oral Health and Systemic Diseases group researcher Jan Potempa, PhD, DSc, and an international team of scientists from the European Union's Gums and Joints project have uncovered how the bacterium responsible for periodontal disease, Porphyromonas gingivalisworsens RA by leading to earlier onset, faster progression and greater severity of the disease, including increased bone and cartilage destruction.

For Full Article: http://www.sciencedaily.com/releases/2013/09/130912203327.htm

Website supported by www.aces4ce.com
ACES is the world's leader in providing live webcast dental continuing education

Disclaimer

Content on this blog are for informational purposes only, is neither intended to and does not establish a standard of care, and is not a substitute for professional judgment, advice, diagnosis, or treatment. ACES is not responsible for information on external websites linked to this website.

Tuesday, June 17, 2014

High-Dose Statins Reduce Gum Inflammation in Heart Disease Patients

Statins, commonly prescribed medications for lowering cholesterol, also reduced inflammation associated with gum disease in a new study published in the Journal of the American College of Cardiology. The study suggests that steps taken to reduce gum disease may also reduce inflammation in the arteries and vice versa.

Periodontal disease is characterized by chronic gum inflammation and affects approximately 50 percent of the U.S. adult population," said Ahmed Tawkol, MD, co-director of the Cardiac Imaging Trials Program at Massachusetts General Hospital and Harvard Medical School and co-author of the study. "Periodontitis and atherosclerosis are both primarily driven by inflammation. These inflammatory conditions tend to co-exist within individuals and their biologies may be intertwined."

For Full Article: http://www.sciencedaily.com/releases/2013/10/131002185652.htm

Website supported by www.aces4ce.com
ACES is the world's leader in providing live webcast dental continuing education

Disclaimer

Content on this blog are for informational purposes only, is neither intended to and does not establish a standard of care, and is not a substitute for professional judgment, advice, diagnosis, or treatment. ACES is not responsible for information on external websites linked to this website.

Tuesday, June 3, 2014

Dental cavities linked to lower risk of head and neck cancer

According to a surprising new study, people who have more dental cavities are at lower risk of being diagnosed with head and neck cancer, compared with patients who have few or no cavities.

Dental cavities (or caries) are caused by tooth decay. This is when the bacteria present in the mouth make lactic acids that strip away minerals in the tooth by fermenting carbohydrates.

For Full Article: http://www.medicalnewstoday.com/articles/265996.php

Website supported by www.aces4ce.com
ACES is the world's leader in providing live webcast dental continuing education

Disclaimer

Content on this blog are for informational purposes only, is neither intended to and does not establish a standard of care, and is not a substitute for professional judgment, advice, diagnosis, or treatment. ACES is not responsible for information on external websites linked to this website.

Tuesday, April 22, 2014

Postmenopausal women who smoked are more likely to lose teeth due to periodontal disease

BUFFALO, N.Y. – Postmenopausal women who have smoked are at much higher risk of losing their teeth than women who never smoked, according to a new study published and featured on the cover of the Journal of the American Dental Association by researchers at the University at Buffalo.

The study involved 1,106 women who participated in the Buffalo OsteoPerio Study, an offshoot of the Women’s Health Initiative, (WHI), the largest clinical trial and observational study ever undertaken in the U.S., involving more than 162,000 women across the nation, including nearly 4,000 in Buffalo.

For Full Article: http://www.buffalo.edu/news/releases/2013/03/002.html

Website supported by www.aces4ce.com
ACES is the world's leader in providing live webcast dental continuing education

Disclaimer

Content on this blog are for informational purposes only, is neither intended to and does not establish a standard of care, and is not a substitute for professional judgment, advice, diagnosis, or treatment. ACES is not responsible for information on external websites linked to this website.

Tuesday, April 8, 2014

In heart disease patients, gum inflammation reduced by high-dose statins

Statins, commonly prescribed medications for lowering cholesterol, also reduced inflammation associated with gum disease in a new study published in the Journal of the American College of Cardiology. The study suggests that steps taken to reduce gum disease may also reduce inflammation in the arteries and vice versa.

"Periodontal disease is characterized by chronic gum inflammation and affects approximately 50 percent of the U.S. adult population," said Ahmed Tawkol, MD, co-director of the Cardiac Imaging Trials Program at Massachusetts General Hospital and Harvard Medical School and co-author of the study. "Periodontitis and atherosclerosis are both primarily driven by inflammation. These inflammatory conditions tend to co-exist within individuals and their biologies may be intertwined."

For Full article: http://www.medicalnewstoday.com/releases/266943.php

Website supported by www.aces4ce.com
ACES is the world's leader in providing live webcast dental continuing education

Disclaimer

Content on this blog are for informational purposes only, is neither intended to and does not establish a standard of care, and is not a substitute for professional judgment, advice, diagnosis, or treatment. ACES is not responsible for information on external websites linked to this website.

Tuesday, February 18, 2014

FDA Issues Final Regulation on Dental Amalgam

The U.S. Food and Drug Administration today issued a final regulation classifying dental amalgam and its component parts – elemental mercury and a powder alloy—used in dental fillings. While elemental mercury has been associated with adverse health effects at high exposures, the levels released by dental amalgam fillings are not high enough to cause harm in patients.

The regulation classifies dental amalgam into Class II (moderate risk). By classifying a device into Class II, the FDA can impose special controls (in addition to general controls such as good manufacturing practices that apply to all medical devices regardless of risk) to provide reasonable assurance of the safety and effectiveness of the device.

The special controls that the FDA is imposing on dental amalgam are contained in a guidance document that contains, among other things, recommendations on performance testing, device composition, and labeling statements.

For Full Article: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm173992.htm

Website supported by www.aces4ce.com
ACES is the world's leader in providing live webcast dental continuing education

Disclaimer

Content on this blog are for informational purposes only, is neither intended to and does not establish a standard of care, and is not a substitute for professional judgment, advice, diagnosis, or treatment. ACES is not responsible for information on external websites linked to this website.

Tuesday, January 21, 2014

Health Effects of Dental Amalgam Fillings in Children

Scientists supported by the National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, report in this week’s Journal of the American Medical Association the results of the first-ever randomized clinical trials to evaluate the safety of placing amalgam fillings, which contain mercury, in the teeth of children.

Both studies—one conducted in Europe, the other in the United States—independently reached the conclusion: Children whose cavities were filled with dental amalgam had no adverse health effects. The findings included no detectable loss of intelligence, memory, coordination, concentration, nerve conduction, or kidney function during the 5-7 years the children were followed. The researchers looked for measurable signs of damage to the brain and kidneys because previous studies with adults indicated these organs might be especially sensitive to mercury.

For Full Article: http://www.nidcr.nih.gov/Research/ResearchResults/NewsReleases/ArchivedNewsReleases/NRY2006/PR04182006.htm

Website supported by www.aces4ce.com
ACES is the world's leader in providing live webcast dental continuing education

Disclaimer

Content on this blog are for informational purposes only, is neither intended to and does not establish a standard of care, and is not a substitute for professional judgment, advice, diagnosis, or treatment. ACES is not responsible for information on external websites linked to this website.